Mitoxantrone synergies with tigecycline against Klebsiella pneumoniae
Microbiology Spectrum · 2026
DOI: 10.1128/spectrum.00568-26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2026. Verfasst von Xin Xia und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Molecular Microbiology and Technology of the Ministry of Education, Department …. Hauptthemen laut MEDLINE: Tigecycline, Mitoxantrone, Klebsiella pneumoniae, Anti-Bacterial Agents. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Committee of Tianjin.
Abstract (Originalsprache)
The global health threat of antimicrobial resistance necessitates the development of novel therapeutic strategies. This study identifies the anticancer agent mitoxantrone as a potent antimicrobial against Klebsiella pneumoniae . Through passaging experiments, we demonstrate that resistance to mitoxantrone arises via mutations in the kstR2 gene, leading to the overexpression of the SmvA efflux pump. Transcriptomic analysis reveals that mitoxantrone treatment induces the bacterial SOS response, likely due to DNA damage. Critically, we found that mitoxantrone exhibits a synergistic effect with tigecycline against K. pneumoniae , both in vitro and in a murine wound infection model. Mechanistically, this synergy is driven by tigecycline-mediated enhancement of intracellular mitoxantrone accumulation. These findings reveal a potentially effective combination regimen to combat K. pneumoniae infections. IMPORTANCE The rise of antibiotic-resistant Klebsiella pneumoniae demands new treatment options. This study uncovers that mitoxantrone, a drug currently approved for cancer therapy, is effective against K. pneumoniae . Furthermore, we discovered that combining mitoxantrone with the existing antibiotic tigecycline is synergistic against K. pneumoniae . We found that tigecycline enhances mitoxantrone accumulation inside bacterial cells. Overall, our work identified the tigecycline-mitoxantrone combination as a promising strategy to treat K. pneumoniae infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Molecular Microbiology and Technology of the Ministry of Education, Department of Microbiology, College of Life Sciences, Nankai University, Tianjin,…
- Department of Laboratory Medicine, Fifth Medical Center of PLA General Hospital, Beijing, China.
ORCID-Profile: Xin Xia, Yongxin Jin, Weihui Wu
Förderung
- National Natural Science Foundation of China
- Science and Technology Committee of Tianjin
Zitieren
APA
Xia, X., Wei, X., Chen, S., Cheng, Z., Jin, Y., Jin, S., & Wu, W. (2026). Mitoxantrone synergies with tigecycline against Klebsiella pneumoniae. Microbiology Spectrum. https://doi.org/10.1128/spectrum.00568-26
Vancouver
Xia X, Wei X, Chen S, Cheng Z, Jin Y, Jin S, et al. Mitoxantrone synergies with tigecycline against Klebsiella pneumoniae. Microbiology Spectrum. 2026. doi:10.1128/spectrum.00568-26
BibTeX
@article{Xia2026,
author = {Xia, Xin and Wei, Xiaoya and Chen, Shuiping and Cheng, Zhihui and Jin, Yongxin and Jin, Shouguang and Wu, Weihui},
title = {Mitoxantrone synergies with tigecycline against Klebsiella pneumoniae},
journal = {Microbiology Spectrum},
year = {2026},
doi = {10.1128/spectrum.00568-26}
}
EUVIMED